On 15 July, global B2B events and media group, Tarsus, announced it had completed the acquisition of BodySite Digital Health, a digital patient care management and education platform.
The company says the acquisition is intended to fast-track Tarsus Medical’s omnichannel strategy to provide digital services and products alongside its programme of live and virtual events and continuing medical education, particularly in the division’s American Academy of Anti-Aging Medicine (A4M) brand.
A key driver in the US healthcare industry has been the shift from reactive treatment to preventive medicine, with HCPs increasingly concerned with tackling patient issues before they arise and identifying precursors to inform patient care management. As a result, HCPs have also been turning to digital tools to facilitate the delivery and management of patient-based care, focused more strongly on day-to-day treatment and monitoring outside doctors’ offices and hospitals.
BodySite leverages three core functionalities: a remote patient monitoring solution (RPM), telemedicine services and a robust learning management system (LMS). Tarsus suggests the platform’s features are highly valued by its subscribers, many of whom also relied on BodySite to continue to monitor and treat patients when the pandemic made in-person visits difficult.
Commenting on the acquisition, Douglas Emslie, CEO of Tarsus Group, said: “This acquisition represents a very exciting move for Tarsus. Through this acquisition we are seeking to leverage the Tarsus Medical reputation amongst medical professionals and our close access to the US healthcare industry to further develop BodySite and enable the business to reach new customers and markets.”
John Cummings, founder & CEO of Bodysite, added: “We are thrilled to be joining Tarsus Group; this acquisition will allow us to provide even better tools and features for healthcare providers looking to make a greater impact on their patients’ health as well as improve the interactions they have with their patients each day.”
